Quantitative Validation of a Yellow Fever Vaccine Model
- 1 November 2019
- conference paper
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 2113-2120
- https://doi.org/10.1109/bibm47256.2019.8983128
Abstract
An effective yellow fever vaccine has been available since 1937. Nevertheless, questions regarding its use remain poorly understood, such as the ideal dose to confer immunity against the disease, the need for booster dose, the optimal immunization schedule for immunocompetent, immunosuppressed, and children, among other issues. The objective of this work is to demonstrate that computational tools can be used to simulate different scenarios regarding yellow fever vaccination and the immune response of the individuals to this vaccine, thus assisting the response of some of these open questions. In this context, this work presents the results of a computational model of the human immune response to vaccination against yellow fever. The model takes into account essential cells and molecules of the human immune system, such as antigen-presenting cells, B and T lymphocytes, memory cells, and antibodies. The model was able to replicate the levels of antibodies obtained experimentally in different vaccination scenarios, allowing a quantitative validation with experimental data.Keywords
This publication has 17 references indexed in Scilit:
- The Use of Reverse Vaccinology and Molecular Modeling Associated with Cell Proliferation Stimulation Approach to Select Promiscuous Epitopes from Schistosoma mansoniApplied Biochemistry and Biotechnology, 2016
- New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parametersHuman Vaccines & Immunotherapeutics, 2015
- Computational modelling approaches to vaccinologyPharmacological Research, 2015
- Mathematical modeling provides kinetic details of the human immune response to vaccinationFrontiers in Cellular and Infection Microbiology, 2015
- Duration of post-vaccination immunity against yellow fever in adultsVaccine, 2014
- 17DD yellow fever vaccineHuman Vaccines & Immunotherapeutics, 2013
- The Hill equation: a review of its capabilities in pharmacological modellingFundamental & Clinical Pharmacology, 2008
- Applying computational modeling to drug discovery and developmentDrug Discovery Today, 2006
- T-cell antigenic sites tend to be amphipathic structures.Proceedings of the National Academy of Sciences of the United States of America, 1985
- THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATIONThe Journal of Experimental Medicine, 1937